1,2-dioctanoylglycerol has been researched along with Alloxan Diabetes in 5 studies
1,2-dioctanoylglycerol: functions as bioregulator of protein kinase C in human platelets
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimoni, Y | 2 |
| Liu, XF | 2 |
| Nobe, K | 1 |
| Sakai, Y | 1 |
| Momose, K | 1 |
| Thorneloe, KS | 1 |
| Walsh, MP | 1 |
| Lattimer, SA | 2 |
| Sima, AA | 1 |
| Greene, DA | 2 |
5 other studies available for 1,2-dioctanoylglycerol and Alloxan Diabetes
| Article | Year |
|---|---|
Role of PKC in autocrine regulation of rat ventricular K+ currents by angiotensin and endothelin.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; B | 2003 |
Alternations of diacylglycerol kinase in streptozotocin-induced diabetic rats.
Topics: Animals; Aorta; Diabetes Mellitus, Experimental; Diacylglycerol Kinase; Diglycerides; Isotope Labeli | 1998 |
Transmural differences in rat ventricular protein kinase C epsilon correlate with its functional regulation of a transient cardiac K+ current.
Topics: Animals; Diabetes Mellitus, Experimental; Diglycerides; Endocardium; Enzyme Activation; Heart Ventri | 2001 |
In vitro correction of impaired Na+-K+-ATPase in diabetic nerve by protein kinase C agonists.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Diglycerides; Kinetics; Male; Ouaba | 1989 |
Protein kinase C agonists acutely normalize decreased ouabain-inhibitable respiration in diabetic rabbit nerve. Implications for (Na,K)-ATPase regulation and diabetic complications.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Diglycerides; Glycerides; Inositol; | 1986 |